Latest & greatest articles for knee replacement

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on knee replacement or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on knee replacement and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for knee replacement

121. Total knee replacement: an evidence-based analysis

Total knee replacement: an evidence-based analysis Total knee replacement: an evidence-based analysis Total knee replacement: an evidence-based analysis Medical Advisory Secretariat. Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Medical Advisory Secretariat.. Total knee replacement: an evidence-based analysis. Toronto: Medical Advisory (...) Secretariat (MAS). Volume 5(9). 2005 Authors' objectives The aim of this review was to assess the effectiveness, in terms of pain reduction and functional improvement, and costing of total knee replacement (TKR) for people with osteoarthritis for whom less invasive treatments (such as physiotherapy, analgesics, anti-inflammatory drugs, intra-articular steroids, hyaluronic acids, and arthroscopic surgery) have failed. Authors' conclusions There is substantial evidence to indicate that TKR effectively

2005 Health Technology Assessment (HTA) Database.

122. Mini-incision surgery for total knee replacement

Mini-incision surgery for total knee replacement Mini-incision surgery for total knee replacement Mini-incision surgery for total knee replacement National Institute for Clinical Excellence Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation National Institute for Clinical Excellence. Mini-incision surgery for total knee replacement. London: National Institute (...) for Clinical Excellence (NICE) 2005: 2 Authors' objectives This study aims to assess the current evidence on mini-incision surgery for total knee replacement. Authors' conclusions 1.1 Current evidence on the safety and efficacy of mini-incision surgery for total knee replacement does not appear adequate for this procedure to be used without special arrangements for consent and for audit or research. More evidence is required on the long-term safety and efficacy of this procedure and clinicians should

2005 Health Technology Assessment (HTA) Database.

123. A meta-analysis of patellar replacement in total knee arthroplasty

A meta-analysis of patellar replacement in total knee arthroplasty A meta-analysis of patellar replacement in total knee arthroplasty A meta-analysis of patellar replacement in total knee arthroplasty Nizard R S, Biau D, Porcher R, Ravaud P, Bizot P, Hannouche D, Sedel L CRD summary This review compared patellar resurfacing with nonresurfacing during total knee arthroplasty. The authors concluded that although resurfacing appeared superior, it was difficult to draw firm conclusions given (...) Although patellar resurfacing appeared to be superior to nonresurfacing in total knee replacement, it was difficult to draw firm conclusions given the many potential confounding factors. CRD commentary The review addressed a clear question that was defined in terms of the participants, intervention and study design. Relevant sources were searched and attempts were made to reduce the possibility of publication and language bias. Methods were used to minimise reviewer errors and bias in the study

2005 DARE.

124. An economic evaluation of bupivacaine plus fentanyl versus ropivacaine alone for patient-controlled epidural analgesia after total-knee replacement procedure: a double-blinded randomized study

An economic evaluation of bupivacaine plus fentanyl versus ropivacaine alone for patient-controlled epidural analgesia after total-knee replacement procedure: a double-blinded randomized study Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2005 NHS Economic Evaluation Database.

125. Costs and effectiveness of pre- and post-operative home physiotherapy for total knee replacement: randomized controlled trial

Costs and effectiveness of pre- and post-operative home physiotherapy for total knee replacement: randomized controlled trial Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2005 NHS Economic Evaluation Database.

126. Does a pre-operative exercise programme improve mobility and function post-total knee replacement: a mini-review

Does a pre-operative exercise programme improve mobility and function post-total knee replacement: a mini-review Does a pre-operative exercise programme improve mobility and function post-total knee replacement: a mini-review Does a pre-operative exercise programme improve mobility and function post-total knee replacement: a mini-review Lucas B CRD summary This review assessed the efficacy of pre-operative exercises on post-operative mobility and function in adults undergoing total knee (...) replacement. The author concluded that there was no evidence to support the efficacy of such exercises and further research is required. However, the reliability of the conclusion is uncertain given concerns about the literature searches and the poor reporting of review methods. Authors' objectives To assess the effects of pre-operative exercise on the mobility and function of patients following total knee replacement (TKR). Searching MEDLINE, CINAHL, EMBASE and PEDro were searched from inception

2004 DARE.

127. Effect of a flow chart on use of blood transfusions in primary total hip and knee replacement: prospective before and after study Full Text available with Trip Pro

Effect of a flow chart on use of blood transfusions in primary total hip and knee replacement: prospective before and after study Effect of a flow chart on use of blood transfusions in primary total hip and knee replacement: prospective before and after study Effect of a flow chart on use of blood transfusions in primary total hip and knee replacement: prospective before and after study Muller U, Exadaktylos A, Roeder C, Pisan M, Eggli S, Juni P Record Status This is a critical abstract (...) of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The health intervention examined in the study was a flow chart on use of blood transfusion for patients undergoing primary total hip and knee replacement. A team of physicians and nurses developed an algorithm aimed at reducing

2004 NHS Economic Evaluation Database.

128. NIH Consensus Development Conference on Total Knee Replacement

NIH Consensus Development Conference on Total Knee Replacement NIH Consensus Statement on Total Knee Replacement NIH Consensus and State-of-the-Science Statements Volume 20, Number 1 December 8–10, 2003 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director About the NIH Consensus Development Program NIH Consensus Development and State-of-the-Science Conferences are convened to evaluate the available scientific evidence on a given biomedical or public (...) bibliographic reference to this consensus statement, it is recommended that the following format be used, with or without source abbreviations, but without authorship attribution: NIH Consensus Statement on Total Knee Replacement. NIH Consens State Sci Statements. 2003 Dec 8–10; 20(1) 1–32. Publications Ordering Information NIH Consensus Statements, State-of-the-Science Statements, and Technol­ ogy Assessment Statements and related materials are available by writing to the NIH Consensus Development Program

2003 NIH Consensus Statements

129. Low-molecular-weight heparin therapy for patients undergoing total knee replacement surgery: cost and outcomes

Low-molecular-weight heparin therapy for patients undergoing total knee replacement surgery: cost and outcomes Low-molecular-weight heparin therapy for patients undergoing total knee replacement surgery: cost and outcomes Low-molecular-weight heparin therapy for patients undergoing total knee replacement surgery: cost and outcomes Allen L R, Bonck M J, Lofgren K L, Mayo K W, Mozaffari E Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion (...) on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The study compared a formulary interchange of low molecular weight heparin (LMWH) products for prophylactic therapy in patients undergoing total knee replacement (TKR) surgery. The products compared were enoxaparin (Lovenox, Aventis) and dalteparin (Fragmin, Pharmacia). Type

2003 NHS Economic Evaluation Database.

130. Total knee replacement

Total knee replacement Total knee replacement Total knee replacement Kane RL, Saleh KJ, Wilt TJ, Bershadsky B, Cross WW III, MacDonald RM, Rutks I Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Kane RL, Saleh KJ, Wilt TJ, Bershadsky B, Cross WW III, MacDonald RM, Rutks I. Total knee replacement. Rockville: Agency for Healthcare Research (...) and Quality (AHRQ). Evidence Report/Technology Assessment No. 86. 2003 Authors' objectives A systematic review of the literature was undertaken to address the following questions: - What are the current indications for, and outcomes from, primary total knee replacement? - How do specific characteristics of the patient, material and design of the prosthesis, and surgical factors, affect the short-term and long-term outcomes of primary total knee replacement? - Are there important perioperative

2003 Health Technology Assessment (HTA) Database.

131. Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement. (Abstract)

Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement. In a previous study of the prevention of venous thromboembolism after total knee replacement, the efficacy of ximelagatran, an oral direct thrombin inhibitor that does not require monitoring of coagulation or dose adjustment, was found to be similar to that of warfarin at a dose of 24 mg of ximelagatran twice daily. The purpose of the present study was to determine whether (...) percent vs. 4.1 percent; P=0.17).The efficacy of oral ximelagatran, administered starting the morning after total knee replacement, was superior to that of warfarin for prevention of venous thromboembolism. Rates of hemorrhagic complications with the two drugs were similar.Copyright 2003 Massachusetts Medical Society

2003 NEJM Controlled trial quality: predicted high

132. Effects of perioperative administration of a selective cyclooxygenase 2 inhibitor on pain management and recovery of function after knee replacement: a randomized controlled trial. Full Text available with Trip Pro

Effects of perioperative administration of a selective cyclooxygenase 2 inhibitor on pain management and recovery of function after knee replacement: a randomized controlled trial. Controlling postoperative pain after knee replacement while reducing opioid-induced adverse effects and improving outcomes remains an important challenge.To assess the effect of combined preoperative and postoperative administration of a selective inhibitor of cyclooxygenase 2 on opioid consumption and outcomes after (...) total knee arthroplasty (TKA).Randomized, placebo-controlled, double-blind trial conducted June 2001 through September 2002, enrolling 70 patients aged 40 to 77 years and undergoing TKA at a university hospital in the United States.Patients were randomly assigned to receive 50 mg of oral rofecoxib at 24 hours and at 1 to 2 hours before TKA, 50 mg daily for 5 days postoperatively, and 25 mg daily for another 8 days, or matching placebo at the same times.Postoperative outcomes including postsurgical

2003 JAMA Controlled trial quality: predicted high

133. The St. Leger total knee replacement: a false economy

Knee Scores in either group meant that it was impossible to quantify the degree of improvement that the patients derived from their operations. Implications of the study This study showed that substituting one total condylar knee replacement for a similar prosthesis did not ensure that the results with the new prosthesis would be similar. The authors did not make any specific recommendations for changes in policy or practice and/or the need for further research. An adequately powered, prospective (...) The St. Leger total knee replacement: a false economy The St. Leger total knee replacement: a false economy The St. Leger total knee replacement: a false economy Westwood M J, White S P, Bannister G C Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions

2003 NHS Economic Evaluation Database.

134. Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO II randomised trial. (Abstract)

Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO II randomised trial. Heparins substantially reduce the risk of thromboembolic complications after total hip or knee replacement. However, they can be given only by injection and have several other drawbacks. We did a multicentre, randomised, double-blind study to examine the dose-response relation of subcutaneous melagatran, a direct thrombin inhibitor (...) , followed by oral ximelagatran as thromboprophylaxis after total hip or knee replacement. We aimed to compare the efficacy and safety with that of dalteparin.Of 1900 patients, 1495 were assigned to four dose categories of subcutaneous melagatran from just before surgery (1.00 mg, 1.50 mg, 2.25 mg, or 3.00 mg twice daily) followed from the day after surgery by oral ximelagatran (8 mg, 12 mg, 18 mg, or 24 mg twice daily). 381 patients were assigned subcutaneous dalteparin 5000 IU once daily, from

2002 Lancet Controlled trial quality: predicted high

135. Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes

Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic (...) outcomes Douketis J D, Eikelboom J W, Quinlan D J, Willan A R, Crowther M A Authors' objectives To provide reliable estimates of the risk of symptomatic venous thromboembolism (VTE), occurring within 3 months of hip or knee replacement in patients who received short-duration (7 to 10 days) anticoagulant prophylaxis. Searching MEDLINE, EMBASE and the Cochrane Controlled Trials Register were searched for studies of anticoagulant prophylaxis after hip or knee replacement that were published between

2002 DARE.

136. Cost/death averted with venous thromboembolism prophylaxis in patients undergoing total knee replacement or knee arthroplasty

Cost/death averted with venous thromboembolism prophylaxis in patients undergoing total knee replacement or knee arthroplasty Cost/death averted with venous thromboembolism prophylaxis in patients undergoing total knee replacement or knee arthroplasty Cost/death averted with venous thromboembolism prophylaxis in patients undergoing total knee replacement or knee arthroplasty Nerurkar J, Wade W E, Martin B C Record Status This is a critical abstract of an economic evaluation that meets (...) the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Two prophylaxis modalities for deep vein thrombosis (DVT) and pulmonary embolism (PE) in patients who had undergone total knee replacement (TKR) were studied. The use of low molecular weight heparin or adjusted-dose warfarin was considered. Type of intervention Primary

2002 NHS Economic Evaluation Database.

137. Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement

Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement Bell G K, Goldhaber S Z Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief (...) summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Low molecular weight heparins (LMWHs) were compared with warfarin for prophylaxis following total hip (THR) or total knee (TKR) replacement. Type of intervention Primary prevention. Economic study type Cost-effectiveness analysis. Study population The study population comprised hospital records from patients admitted for THR and TKR

2001 NHS Economic Evaluation Database.

138. The Oxford unicompartmental knee replacement for osteoarthritis

The Oxford unicompartmental knee replacement for osteoarthritis The Oxford unicompartmental knee replacement for osteoarthritis The Oxford unicompartmental knee replacement for osteoarthritis Brown A Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Brown A. The Oxford unicompartmental knee replacement for osteoarthritis. Ottawa: Canadian (...) Coordinating Office for Health Technology Assessment/Office Canadien de Coordination de l'Evaluation des Technologies de la Sante (CCOHTA) 2001: 4 Authors' objectives To summarise the available evidence on the use of the Oxford unicompartmental knee replacement for osteoarthritis. Authors' conclusions The Oxford unicompartmental knee replacement is a reliable treatment for medial knee compartment osteoarthritis, provided patients with the correct indications are chosen and the appropriate surgical

2001 Health Technology Assessment (HTA) Database.

139. Autologous blood transfusion in total knee replacement surgery

Autologous blood transfusion in total knee replacement surgery Autologous blood transfusion in total knee replacement surgery Autologous blood transfusion in total knee replacement surgery Thomas D, Wareham K, Cohen D, Hutchings H Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability (...) of the study and the conclusions drawn. Health technology Autologous blood transfusion (transfusion using post-operative red cell salvage (PRCS)) was assessed. This involved the use of collected blood which was washed and re-suspended in saline before re-infusion using a centrifugal cell washing machine (Cell Saver 5 Haemonetics). Type of intervention Treatment. Economic study type Cost-effectiveness analysis. Study population The study population comprised patients undergoing total knee replacement (TKR

2001 NHS Economic Evaluation Database.

140. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials

Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2001 DARE.